{
 "drug": "Methotrexate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "08/29/2025",
 "dayN": 361,
 "cat": "Rheumatology",
 "companies": [
  "Assertio Specialty Pharmaceuticals, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "08/29/2025",
   "update_type": "New",
   "initial_posting_date": "08/29/2025",
   "package_ndc": "82497-012-04",
   "generic_name": "Methotrexate Injection",
   "contact_info": "224-441-6390",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/29/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Otrexup, Injection, 12.5 mg/.4 mL (NDC 82497-012-04)",
   "company_name": "Assertio Specialty Pharmaceuticals, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/29/2025",
   "update_type": "New",
   "initial_posting_date": "08/29/2025",
   "package_ndc": "82497-015-04",
   "generic_name": "Methotrexate Injection",
   "contact_info": "224-441-6390",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/29/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Otrexup, Injection, 15 mg/.4 mL (NDC 82497-015-04)",
   "company_name": "Assertio Specialty Pharmaceuticals, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/29/2025",
   "update_type": "New",
   "initial_posting_date": "08/29/2025",
   "package_ndc": "82497-017-04",
   "generic_name": "Methotrexate Injection",
   "contact_info": "224-441-6390",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/29/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Otrexup, Injection, 17.5 mg/.4 mL (NDC 82497-017-04)",
   "company_name": "Assertio Specialty Pharmaceuticals, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/29/2025",
   "update_type": "New",
   "initial_posting_date": "08/29/2025",
   "package_ndc": "82497-022-04",
   "generic_name": "Methotrexate Injection",
   "contact_info": "224-441-6390",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/29/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Otrexup, Injection, 22.5 mg/.4 mL (NDC 82497-022-04)",
   "company_name": "Assertio Specialty Pharmaceuticals, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/29/2025",
   "update_type": "New",
   "initial_posting_date": "08/29/2025",
   "package_ndc": "82497-010-04",
   "generic_name": "Methotrexate Injection",
   "contact_info": "224-441-6390",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/29/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Otrexup, Injection, 10 mg/.4 mL (NDC 82497-010-04)",
   "company_name": "Assertio Specialty Pharmaceuticals, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/29/2025",
   "update_type": "New",
   "initial_posting_date": "08/29/2025",
   "package_ndc": "82497-020-04",
   "generic_name": "Methotrexate Injection",
   "contact_info": "224-441-6390",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/29/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Otrexup, Injection, 20 mg/.4 mL (NDC 82497-020-04)",
   "company_name": "Assertio Specialty Pharmaceuticals, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/29/2025",
   "update_type": "New",
   "initial_posting_date": "08/29/2025",
   "package_ndc": "82497-025-04",
   "generic_name": "Methotrexate Injection",
   "contact_info": "224-441-6390",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/29/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Otrexup, Injection, 25 mg/.4 mL (NDC 82497-025-04)",
   "company_name": "Assertio Specialty Pharmaceuticals, LLC",
   "status": "To Be Discontinued"
  }
 ]
}